ESM1 and glioblastoma: RNA-seq and subsequent GSEA revealed that their effect on GBM cells was similar but not precisely the same (Fig. 4e), indicating that while Endocan can activate the PDGFRA receptor, it might also have effects that are distinct from those of other PDGFR ligands, possibly due to the binding with other cellular receptors.